1 week 16
Extreme 16
19.7
1 month 16
Extreme 16
19.7
Current year 16
Extreme 16
19.7
1 year 16
Extreme 16
19.7
3 years 16
Extreme 16
19.7
5 years 16
Extreme 16
19.7
10 years 16
Extreme 16
19.7
Manager TitleAgeSince
Chief Executive Officer 48 01/01/2020
Chief Tech/Sci/R&D Officer 54 01/01/2020
Director of Finance/CFO 44 01/01/2025
Director TitleAgeSince
Director/Board Member 54 01/01/2020
Director/Board Member 78 01/03/2023
Director/Board Member 48 01/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+18.19%0.00% - - 896M
+1.08%+3.22%+5.07%+64.60% 4,006B
-0.23%+0.87%+11.62%+1,054.95% 482B
+3.00%-0.90%-55.71%+24.22% 408B
-1.27%-7.08%+79.13%+185.48% 303B
-1.89%-7.01%+100.05%+426.75% 251B
+0.56%+5.87%-13.08%+65.25% 260B
+6.14%+6.31%-17.74%+35.15% 154B
-1.16%-3.80%+117.65%+214.94% 133B
-1.14%-2.76%+66.39%+202.35% 95.6B
Average +1.28%-0.46%+32.60%+252.63% 609.27B
Weighted average by Cap. -1.12%+0.27%+11.19%+165.90%

Financials

2024 2025
Net sales 1.19M 1.07M 991K 901K 1.7M 113M 1.73M 11.9M 4.66M 59M 4.48M 4.39M 189M 9.43M 8.41M 7.82M 7.11M 13.38M 893M 13.62M 93.93M 36.75M 466M 35.37M 34.62M 1.49B
Net income -47.88M -42.74M -39.72M -36.13M -67.97M -4.53B -69.2M -477M -187M -2.37B -180M -176M -7.57B -77.3M -68.99M -64.12M -58.33M -110M -7.32B -112M -770M -301M -3.82B -290M -284M -12.22B
Net Debt - -
Projected Income Statement - Annual - Iambic Therapeutics, Inc.
Date Price Change Volume
15/10/26 $18.91 +18.19% 2,015,121
14/10/26 $16.00 0.00% 0